A new polyoxovanadium cluster compound, [VO{(OCHCH)N(CHCHOH)}]·0.5CHCN, was synthesized and characterized by single-crystal X-ray diffraction analysis, FTIR and UV-vis spectroscopy, and TGA. The cluster is composed of a fully reduced cyclic {VNO} framework, which adopts an Anderson-like structure and is comprised of a ring of six edge-sharing {VON} octahedra incorporating six {(OCHCH)N(CHCHOH)} ligands. Two (OCHCH-) arms of each of the six triethanolamine ligands are directly incorporated into the oxometalate core and the third {-CHCHOH} arm remains pendant. In the condensed phase, the clusters form discrete hcp layers through inter-cluster hydrogen bonding. These layers stack through soft chemical interactions to form a 3D network structure. The neutral cluster, [VO{(OCHCH)N(CHCHOH)}], is the isopolyoxovanadium analogue to the cationic clusters contained in a series of heteropolyoxovanadium compounds previously introduced by our laboratory, e.g., [LiVO{(OCHCH)N(CHCHOH)}]; its existence shows that a heteroatom is not required to form or stabilize the common organofunctionalized vanadium oxide framework: [VO{(OCHCH)N(CHCHOH)}]. To the best of our knowledge, the isopolyoxovanadium and heteropolyoxovanadium clusters represent the first reported isopoly-heteropoly analogues in the polyoxometalate field. We compare the TGA profile, FTIR and UV-vis spectra of the new compound with two of its cationic heteropoly analogues.
A new diethanolamine functionalized oxovanadium cationic cluster was synthesized and characterized; electrochemical and UV-vis absorption properties are consistent with two distinct MLCT processes.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.